Announced
Completed
Financials
Sources
Tags
United States
Majority
Completed
non-prescription pharmaceuticals
Friendly
health products
Cross Border
Pharmaceuticals
Single Bidder
Acquisition
Private
Synopsis
Kobayashi Pharmaceutical, a manufacturer of pharmaceuticals and medical equipment, completed the acquisition of Alva-Amco, a US producer of specialty non-prescription pharmaceuticals, dietary supplements, and skin care products, for $108m. This key strategic acquisition continues expansion of Kobayashi’s healthcare business in North America. Both companies have an extensive range of healthcare products and experience to draw upon to build a platform for future growth. Combining Kobayashi’s R&D and technical knowledge with their marketing and sales capabilities on the brands, aiming to further grow healthcare business in North America by providing new value to customers.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.